UNSPSC 51422338: Dexamethasone metasulfobenzoate sodium

This classification denotes a therapeutic glucocorticoid and antiemetic agent with the molecular formula C22H29FO5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 7S5I7G3JQL, chemically known as 9-fluoro-11.beta.,17, 21-trihydroxy-16.beta.-methylpregna-1,4-diene-3,20-dione but more generally known as dexamethasone, which bears US NIH Compound Identifier 3003. European Medicines Agency schedules Dexamethasone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07017MIG.

UNSPSC 51422338 Dexamethasone metasulfobenzoate sodium is a Commodity code that in practice captures pharmaceutical and medical products procured by state and local health agencies, though recent solicitation activity under this code shows minimal alignment with the nominal pharmaceutical scope. The single recent opportunity tagged to this code — Seminole County, Florida's IFB for naloxone and drug deactivation systems — represents emergency-response medical supplies rather than the specific corticosteroid named in the code taxonomy. State and local procurement offices appear to use this code infrequently or inconsistently when classifying pharmaceutical and medical-supply purchases, resulting in limited visibility into what is actually being bought under it at the Commodity tier.

Seminole County, Florida posted IFB 60459723LAS on June 30, 2026, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford. The bid deadline was July 26, 2023, with electronic submission required through the county's e-Procurement Portal and shipping costs to be included in vendor proposals. The contract structure includes a two-year initial term with one-year renewal option, drug-free workplace certification, E-Verify compliance, and potential FEMA funding with associated federal compliance requirements. This appears to be the primary recent state or local procurement activity visible under the code; the mismatch between the code's pharmaceutical specificity and the naloxone/deactivation-systems solicitation suggests either inconsistent code application in the source data or limited procurement volume under this Commodity designation across state and local jurisdictions.